In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis

MLA

Saradee Warit, et al. “In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium Tuberculosis.” Scientia Pharmaceutica, vol. 85, no. 3, Sept. 2017, p. 32. EBSCOhost, https://doi.org/10.3390/scipharm85030032.

APA

Saradee Warit, Kamolchanok Rukseree, Therdsak Prammananan, Poonpilas Hongmanee, Pamaree Billamas, Sarinya Jaitrong, Angkana Chaiprasert, Birgit U. Jaki, Guido F. Pauli, Scott G. Franzblau, & Prasit Palittapongarnpim. (2017). In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosis. Scientia Pharmaceutica, 85(3), 32. https://doi.org/10.3390/scipharm85030032

Chicago

Saradee Warit, Kamolchanok Rukseree, Therdsak Prammananan, Poonpilas Hongmanee, Pamaree Billamas, Sarinya Jaitrong, Angkana Chaiprasert, et al. 2017. “In Vitro Activities of Enantiopure and Racemic 1′-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium Tuberculosis.” Scientia Pharmaceutica 85 (3): 32. doi:10.3390/scipharm85030032.